Theaflavin 3,3'-di-O-gallateCAS# 30462-35-2 |
2D Structure
- Theaflavine-3,3'-digallate
Catalog No.:BCN5420
CAS No.:33377-72-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 30462-35-2 | SDF | Download SDF |
PubChem ID | 135403795 | Appearance | Red-purple powder |
Formula | C43H32O20 | M.Wt | 868.70 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Synonyms | Theaflavin 3 | ||
Solubility | DMSO : 41.67 mg/mL (47.97 mM; Need ultrasonic) | ||
Chemical Name | [(2R,3R)-2-[1-[(2R,3R)-5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyl)oxy-3,4-dihydro-2H-chromen-2-yl]-3,4,6-trihydroxy-5-oxobenzo[7]annulen-8-yl]-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate | ||
SMILES | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC4=C(C(=C(C=C4C5C(CC6=C(C=C(C=C6O5)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)C(=O)C(=C3)O)OC(=O)C8=CC(=C(C(=C8)O)O)O | ||
Standard InChIKey | ZEASWHWETFMWCV-ISBUVJFSSA-N | ||
Standard InChI | InChI=1S/C43H32O20/c44-17-7-23(46)21-12-33(62-42(58)15-3-25(48)36(54)26(49)4-15)40(60-31(21)9-17)14-1-19-20(11-30(53)39(57)35(19)38(56)29(52)2-14)41-34(13-22-24(47)8-18(45)10-32(22)61-41)63-43(59)16-5-27(50)37(55)28(51)6-16/h1-11,33-34,40-41,44-51,53-55,57H,12-13H2,(H,52,56)/t33-,34-,40-,41-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Theaflavin-3,3'-digallate(TF3), an inducer of oxidative stress, which has anti-inflammatory and cancer chemopreventive actions, it reduces tumor angiogenesis by downregulating HIF-1αand VEGF; suggests that TF3 might serve as a potential anti-angiogenic agent for cancer treatment. TF3 and lactic acid combinations can reduce Herpes Simplex Virus(HSV) infectivity. |
Targets | NF-kB | EGFR | HIF | NO | HSV |
In vitro | Increase of theaflavin gallates and thearubigins by acceleration of catechin oxidation in a new fermented tea product obtained by the tea-rolling processing of loquat ( Eriobotrya japonica ) and green tea leaves.[Pubmed: 19507893]J Agric Food Chem. 2009 Jul 8;57(13):5816-22.In a project to produce a new fermented tea product from non-used tea leaves harvested in the summer, we found that kneading tea leaves ( Camellia sinensis ) with fresh loquat leaves ( Eriobotrya japonica ) accelerated the enzymatic oxidation of tea catechins. Evaluation of the anti-oxidative effect (in vitro) of tea polyphenols.[Pubmed: 12729007]Biosci Biotechnol Biochem. 2003 Feb;67(2):396-401.Forty-three polyphenols from tea leaves were evaluated for their anti-oxidative effect against lipid peroxidation by the ferric thiocyanate method in vitro. Theaflavin-3,3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages.[Pubmed: 10079014]Eur J Pharmacol. 1999 Feb 19;367(2-3):379-88.
|
Kinase Assay | Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3'-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages.[Pubmed: 10644043]Biochem Pharmacol. 2000 Feb 15;59(4):357-67.
|
Theaflavin 3,3'-di-O-gallate Dilution Calculator
Theaflavin 3,3'-di-O-gallate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.1511 mL | 5.7557 mL | 11.5115 mL | 23.0229 mL | 28.7786 mL |
5 mM | 0.2302 mL | 1.1511 mL | 2.3023 mL | 4.6046 mL | 5.7557 mL |
10 mM | 0.1151 mL | 0.5756 mL | 1.1511 mL | 2.3023 mL | 2.8779 mL |
50 mM | 0.023 mL | 0.1151 mL | 0.2302 mL | 0.4605 mL | 0.5756 mL |
100 mM | 0.0115 mL | 0.0576 mL | 0.1151 mL | 0.2302 mL | 0.2878 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Theaflavin-3-gallate
Catalog No.:BCN2316
CAS No.:30462-34-1
- Cyclomusalenone
Catalog No.:BCN4654
CAS No.:30452-60-9
- AVE 0991
Catalog No.:BCC4032
CAS No.:304462-19-9
- Dynasore
Catalog No.:BCC1088
CAS No.:304448-55-3
- Toxicarolisoflavone
Catalog No.:BCN6468
CAS No.:3044-60-8
- Pelirine
Catalog No.:BCN4077
CAS No.:30435-26-8
- Corydalmine
Catalog No.:BCN5217
CAS No.:30413-84-4
- LU AA33810
Catalog No.:BCC7708
CAS No.:304008-29-5
- Harmaline
Catalog No.:BCN5218
CAS No.:304-21-2
- Hydralazine HCl
Catalog No.:BCC4911
CAS No.:304-20-1
- Reutericyclin
Catalog No.:BCN1855
CAS No.:303957-69-9
- U 18666A
Catalog No.:BCC7136
CAS No.:3039-71-2
- Xerophilusin G
Catalog No.:BCN5219
CAS No.:304642-94-2
- S 24795
Catalog No.:BCC7700
CAS No.:304679-75-2
- Flunarizine 2HCl
Catalog No.:BCC4398
CAS No.:30484-77-6
- Mearnsitrin
Catalog No.:BCN5220
CAS No.:30484-88-9
- Tanaproget
Catalog No.:BCC1984
CAS No.:304853-42-7
- Alisol C
Catalog No.:BCN3458
CAS No.:30489-27-1
- AGK 2
Catalog No.:BCC7609
CAS No.:304896-28-4
- SANT-1
Catalog No.:BCC3941
CAS No.:304909-07-7
- 6,7-Dihydroxycoumarin
Catalog No.:BCN5905
CAS No.:305-01-1
- Chlorambucil
Catalog No.:BCC5351
CAS No.:305-03-3
- L-carnosine
Catalog No.:BCN3803
CAS No.:305-84-0
- Licoricidin
Catalog No.:BCN6679
CAS No.:30508-27-1
Increase of theaflavin gallates and thearubigins by acceleration of catechin oxidation in a new fermented tea product obtained by the tea-rolling processing of loquat ( Eriobotrya japonica ) and green tea leaves.[Pubmed:19507893]
J Agric Food Chem. 2009 Jul 8;57(13):5816-22.
In a project to produce a new fermented tea product from non-used tea leaves harvested in the summer, we found that kneading tea leaves ( Camellia sinensis ) with fresh loquat leaves ( Eriobotrya japonica ) accelerated the enzymatic oxidation of tea catechins. The fermented tea obtained by tea-rolling processing of tea and loquat leaves had a strong, distinctive flavor and a plain aftertaste, which differed from usual black, green, and oolong teas. The phenolic constituents were similar to those of black tea. However, the concentrations of theaflavin 3-O-gallate, theaflavin 3,3'-di-O-gallate, and thearubigins were higher in the tea leaves kneaded with loquat leaves than in tea leaves kneaded without loquat leaves. The results from in vitro experiments suggested that acceleration of catechin oxidation was caused by the strong oxidation activity of loquat leaf enzymes and a coupled oxidation mechanism with caffeoyl quinic acids, which are the major phenolic constituents of loquat leaves.
Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3'-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages.[Pubmed:10644043]
Biochem Pharmacol. 2000 Feb 15;59(4):357-67.
We investigated the inhibition of IkappaB kinase (IKK) activity in lipopolysaccharide (LPS)-activated murine macrophages (RAW 264.7 cell line) by various polyphenols including (-)-epigallocatechin-3-gallate, theaflavin, a mixture of theaflavin-3 gallate and theaflavin-3'-gallate, theaflavin-3,3'-digallate (TF-3), pyrocyanidin B-3, casuarinin, geraniin, and penta-O-galloyl-beta-D-glucose (5GG). TF-3 inhibited IKK activity in activated macrophages more strongly than did the other polyphenols. TF-3 strongly inhibited both IKK1 and IKK2 activity and prevented the degradation of IkappaBalpha and IkappaBbeta in activated macrophage cells. The results suggested that the inhibition of IKK activity by TF-3 could occur by a direct effect on IKKs or on upstream events in the signal transduction pathway. Furthermore, geraniin, 5GG, and TF-3 all blocked phosphorylation of IKB from the cytosolic fraction, inhibited nuclear factor-kappaB (NFkappaB) activity, and inhibited increases in inducible nitric oxide synthase levels in activated macrophages. These results suggest that TF-3 may exert its anti-inflammatory and cancer chemopreventive actions by suppressing the activation of NFkappaB through inhibition of IKK activity.
Evaluation of the anti-oxidative effect (in vitro) of tea polyphenols.[Pubmed:12729007]
Biosci Biotechnol Biochem. 2003 Feb;67(2):396-401.
Forty-three polyphenols from tea leaves were evaluated for their anti-oxidative effect against lipid peroxidation by the ferric thiocyanate method in vitro. Among these, 1,4,6-tri-O-galloyl-beta-D-glucose (hydrolyzable tannin) showed the highest anti-oxidative activity against lipid peroxidation, even stronger than that of 3-tert.-butyl-4-hydroxyanisole (BHA). The assay demonstrates that tea polyphenols, except for desgalloylated dimeric proanthocyanidins that possess a catechin structure in the upper unit and desgalloylated flavan-3-ols, and excepting theaflavin 3,3'-di-O-gallate, had more anti-oxidative activity than that of alpha-tocopherol. The chemical structure-activity relationship shows that the anti-oxidative action advanced with the condensation of two molecules of flavan-3-ols as well as with 3-O-acylation in the flavan skeleton such as that by galloyl, (3'-O-methyl)-galloyl, and p-coumaroyl groups.
Theaflavin-3,3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages.[Pubmed:10079014]
Eur J Pharmacol. 1999 Feb 19;367(2-3):379-88.
Nitric oxide (NO) plays an important role in inflammation and also in multiple stages of carcinogenesis. We investigated the effects of various tea polyphenols, including theaflavin, a mixture of theaflavin-3-gallate and theaflavin-3'-gallate, theaflavin-3,3'-digallate, thearubigin, and (-)-epigallocatechin-3-gallate on the induction of NO synthase in lipopolysaccharide-activated murine macrophages, RAW 264.7 cells. Theaflavin-3,3'-digallate was found to be stronger than (-)-epigallocatechin-3-gallate in inhibiting NO generation and inducible NO synthase protein in activated macrophages, while theaflavin, a mixture of theaflavin-3-gallate and theaflavin-3'-gallate and thearubigin were less effective. Inhibition of NO production was observed when cells were cotreated with theaflavin-3,3'-digallate and lipopolysaccharide. Western blot and reverse transcriptase-polymerase chain reaction (RT-PCR) analyses demonstrated that significantly reduced 130-kDa protein and mRNA levels of inducible NO synthase were expressed in lipopolysacchride-activated macrophages with theaflavin-3,3'-digallate, compared to those without theaflavin-3,3'-digallate. Electrophoretic mobility shift assay (EMSA) indicated that theaflavin-3,3'-digallate blocked the activation of nuclear factor kappaB (NF-kappaB), a transcription factor necessary for inducible NO synthase induction. Theaflavin-3,3'-digallate also blocked phosphorylation of IkappaB from cytosolic fraction and reduced lipopolysacchride-induced nuclear accumulation of transcription factor NF-kappaB p65 and p50 subunits. These results suggest that theaflavin-3,3'-digallate decreases the protein levels of inducible NO synthase by reducing the expression of inducible NO synthase mRNA, and the reduction could be via preventing the activation of NF-kappaB, thereby inhibiting the induction of inducible NO synthase transcription. It was also demonstrated that the gallic acid moiety of theaflavin-3,3'-digallate is essential for their potent anti-inflammation activity.